Active Pharmaceutical Ingredients (API) Market Analysis by Growth Rate and Trends with Forecast to 2025
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Cancer, neurological disorders & CNS, endocrinal disorders <strong>and</strong> cardiovascular diseases are some of the major<br />
applications of the <strong>API</strong>. In 2015, CVD (cardiovascular diseases) dominated the market owing <strong>to</strong> its high rate of<br />
prevalence <strong>and</strong> high product availability. CVD has been reported as the major cause of death in the U.S since many<br />
years.<br />
In addition, oncology is expected <strong>to</strong> be the fastest-growing segment <strong>and</strong> is estimated <strong>to</strong> witness the CAGR of 7% owing<br />
<strong>to</strong> high number of products waiting approval. Moreover, increasing prevalence of cancer worldwide is anticipated <strong>to</strong><br />
further boost market.<br />
See More Reports of this Category <strong>by</strong> Million Insights @:<br />
https://www.millioninsights.com/industry/pharmaceuticals<br />
Regional Insights<br />
In 2015, <strong>API</strong> market was dominated <strong>by</strong> the North America <strong>and</strong> is anticipated <strong>to</strong> retain its position in upcoming years<br />
owing <strong>to</strong> encouraging government initiatives for generic drug usage, rising R&D expenditure, <strong>and</strong> technological<br />
advancements in the drug manufacturing practices.<br />
Asia Pacific is anticipated <strong>to</strong> be the region <strong>with</strong> fastest growth owing <strong>to</strong> the increasing availability of cheap <strong>and</strong><br />
affordable labour. Hence, key major companies are setting up their <strong>API</strong> production plants in developing countries of<br />
Asia Pacific such as China <strong>and</strong> India.<br />
Competitive Insights<br />
One of the key manufacturers of the <strong>API</strong> (<strong>Active</strong> pharmaceutical ingredients) is Teva <strong>Pharmaceutical</strong>s Ltd. Some of the<br />
additional key players in this industry includes Boehringer Ingelheim GmbH, AbbVie, Inc., Merck & Co., Inc. <strong>and</strong> Cipla,<br />
Inc., New molecule launches, collaborations, acquisitions, <strong>and</strong> regional expansions are some strategic initiatives taken<br />
<strong>by</strong> these Key players <strong>to</strong> retain their position.